Atossa Genetics Discloses Net Losses of $3.4M in FY 2011, $1.1M in Q1 2012 | GenomeWeb

NEW YORK (GenomeWeb News) – Atossa Genetics, which refiled for an initial public offering earlier this year, said in its amended Form S-1 that it net loss for full-year 2011 reached $3.4 million.

In a Form S-1/A filed on Friday with the US Securities and Exchange Commission, the Seattle-based breast cancer diagnostic firm added that it recorded $1,500 in revenues for 2011. For the first quarter of 2012, Atossa posted revenues of $54,713 with a net loss of $1.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.